Raia Drogasil Future Growth
Future criteria checks 4/6
Raia Drogasil is forecast to grow earnings and revenue by 17.4% and 12.3% per annum respectively. EPS is expected to grow by 16.4% per annum. Return on equity is forecast to be 22.6% in 3 years.
Key information
17.4%
Earnings growth rate
16.38%
EPS growth rate
Consumer Retailing earnings growth | 18.4% |
Revenue growth rate | 12.3% |
Future return on equity | 22.65% |
Analyst coverage | Good |
Last updated | 23 May 2025 |
Recent future growth updates
Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models
May 09Raia Drogasil S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Mar 01Earnings Beat: Raia Drogasil S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Nov 08Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Aug 10The Raia Drogasil S.A. (BVMF:RADL3) Yearly Results Are Out And Analysts Have Published New Forecasts
Mar 10Recent updates
Raia Drogasil S.A.'s (BVMF:RADL3) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio
May 11Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models
May 09Is Raia Drogasil (BVMF:RADL3) Using Too Much Debt?
Apr 29Raia Drogasil S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Mar 01Raia Drogasil (BVMF:RADL3) Is Experiencing Growth In Returns On Capital
Feb 24These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well
Jan 19RD Saude's Expansion And Digital Investment Ignite Growth In The Health Market
Expansion and digital investment aim to increase market share and boost revenue via mature store growth and new store openings.Raia Drogasil S.A.'s (BVMF:RADL3) Price In Tune With Earnings
Nov 26Earnings Beat: Raia Drogasil S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Nov 08Raia Drogasil (BVMF:RADL3) Has A Pretty Healthy Balance Sheet
Oct 13Returns Are Gaining Momentum At Raia Drogasil (BVMF:RADL3)
Sep 25Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Aug 10With Raia Drogasil S.A. (BVMF:RADL3) It Looks Like You'll Get What You Pay For
Jul 13Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly
Apr 08Does Raia Drogasil (BVMF:RADL3) Deserve A Spot On Your Watchlist?
Mar 24Investors Met With Slowing Returns on Capital At Raia Drogasil (BVMF:RADL3)
Jan 29Raia Drogasil S.A.'s (BVMF:RADL3) Earnings Haven't Escaped The Attention Of Investors
Dec 29Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?
Dec 12Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?
Nov 27Returns On Capital At Raia Drogasil (BVMF:RADL3) Have Stalled
Oct 27Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?
Sep 07Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?
Aug 19Here's What To Make Of Raia Drogasil's (BVMF:RADL3) Decelerating Rates Of Return
Jul 18Is Raia Drogasil (BVMF:RADL3) Using Too Much Debt?
Jun 03Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?
May 13Returns At Raia Drogasil (BVMF:RADL3) Appear To Be Weighed Down
Apr 10The Raia Drogasil S.A. (BVMF:RADL3) Yearly Results Are Out And Analysts Have Published New Forecasts
Mar 10Is Raia Drogasil (BVMF:RADL3) A Risky Investment?
Feb 27Returns On Capital At Raia Drogasil (BVMF:RADL3) Have Hit The Brakes
Jan 07Here's Why Raia Drogasil (BVMF:RADL3) Has Caught The Eye Of Investors
Dec 07Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly
Nov 22Raia Drogasil (BVMF:RADL3) Could Be Struggling To Allocate Capital
Sep 08Here's Why Raia Drogasil (BVMF:RADL3) Has Caught The Eye Of Investors
Aug 24Is Raia Drogasil (BVMF:RADL3) A Risky Investment?
Aug 09There Are Reasons To Feel Uneasy About Raia Drogasil's (BVMF:RADL3) Returns On Capital
Jun 09With EPS Growth And More, Raia Drogasil (BVMF:RADL3) Is Interesting
May 25Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?
May 10Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?
Feb 24These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well
Feb 09Some Investors May Be Worried About Raia Drogasil's (BVMF:RADL3) Returns On Capital
Dec 07Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?
Nov 19These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well
Nov 04Returns On Capital At Raia Drogasil (BVMF:RADL3) Paint A Concerning Picture
Sep 01Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?
Aug 17These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well
Jul 28Raia Drogasil (BVMF:RADL3) Will Will Want To Turn Around Its Return Trends
May 10We Think Raia Drogasil (BVMF:RADL3) Can Stay On Top Of Its Debt
Mar 10Do Institutions Own Raia Drogasil S.A. (BVMF:RADL3) Shares?
Feb 16Is Raia Drogasil S.A.'s (BVMF:RADL3) Recent Performance Tethered To Its Attractive Financial Prospects?
Jan 29You Have To Love Raia Drogasil S.A.'s (BVMF:RADL3) Dividend
Jan 11Did Business Growth Power Raia Drogasil's (BVMF:RADL3) Share Price Gain of 253%?
Dec 24Is Raia Drogasil (BVMF:RADL3) A Risky Investment?
Dec 03Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 56,386 | 1,822 | 1,144 | 3,154 | 9 |
12/31/2026 | 49,915 | 1,441 | 853 | 2,558 | 12 |
12/31/2025 | 43,766 | 1,120 | 393 | 2,667 | 10 |
3/31/2025 | 39,815 | 1,174 | 1,299 | 2,650 | N/A |
12/31/2024 | 38,864 | 1,198 | 1,500 | 2,784 | N/A |
9/30/2024 | 37,701 | 1,110 | 1,109 | 2,352 | N/A |
6/30/2024 | 36,388 | 1,039 | 441 | 1,664 | N/A |
3/31/2024 | 35,143 | 1,051 | 765 | 2,032 | N/A |
12/31/2023 | 33,974 | 1,055 | 481 | 1,785 | N/A |
9/30/2023 | 32,886 | 1,079 | 714 | 2,034 | N/A |
6/30/2023 | 31,700 | 1,031 | 883 | 2,186 | N/A |
3/31/2023 | 30,436 | 1,048 | 1,007 | 2,248 | N/A |
12/31/2022 | 29,067 | 996 | 493 | 1,682 | N/A |
9/30/2022 | 27,705 | 881 | 563 | 1,590 | N/A |
6/30/2022 | 26,380 | 820 | 871 | 1,805 | N/A |
3/31/2022 | 25,069 | 718 | 322 | 1,232 | N/A |
12/31/2021 | 24,127 | 752 | 701 | 1,557 | N/A |
9/30/2021 | 23,207 | 743 | 772 | 1,577 | N/A |
6/30/2021 | 22,136 | 743 | 984 | 1,737 | N/A |
3/31/2021 | 20,737 | 535 | 716 | 1,349 | N/A |
12/31/2020 | 20,067 | 484 | 801 | 1,477 | N/A |
9/30/2020 | 19,298 | 409 | 620 | 901 | N/A |
6/30/2020 | 18,806 | 713 | 73 | 311 | N/A |
3/31/2020 | 18,562 | 807 | 680 | 969 | N/A |
12/31/2019 | 17,566 | 772 | 462 | 749 | N/A |
9/30/2019 | 16,778 | 803 | 103 | 805 | N/A |
6/30/2019 | 15,933 | 472 | 236 | 985 | N/A |
3/31/2019 | 15,321 | 470 | -46 | 708 | N/A |
12/31/2018 | 14,801 | 502 | N/A | 683 | N/A |
9/30/2018 | 14,306 | 519 | N/A | 570 | N/A |
6/30/2018 | 13,966 | 527 | N/A | 674 | N/A |
3/31/2018 | 13,589 | 528 | N/A | 691 | N/A |
12/31/2017 | 13,213 | 511 | N/A | 629 | N/A |
9/30/2017 | 12,768 | 464 | N/A | 601 | N/A |
6/30/2017 | 12,252 | 444 | N/A | 603 | N/A |
3/31/2017 | 11,798 | 462 | N/A | 597 | N/A |
12/31/2016 | 11,257 | 448 | N/A | 556 | N/A |
9/30/2016 | 10,658 | 438 | N/A | 528 | N/A |
6/30/2016 | 10,042 | 407 | N/A | 390 | N/A |
3/31/2016 | 9,446 | 360 | N/A | 410 | N/A |
12/31/2015 | 8,898 | 340 | N/A | 502 | N/A |
9/30/2015 | 8,448 | 325 | N/A | 505 | N/A |
6/30/2015 | 8,074 | 309 | N/A | 432 | N/A |
3/31/2015 | 7,668 | 263 | N/A | 437 | N/A |
12/31/2014 | 7,351 | 221 | N/A | 340 | N/A |
9/30/2014 | 7,023 | 187 | N/A | 315 | N/A |
6/30/2014 | 6,738 | 138 | N/A | 341 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RADL3's forecast earnings growth (17.4% per year) is above the savings rate (11.2%).
Earnings vs Market: RADL3's earnings (17.4% per year) are forecast to grow faster than the BR market (13.3% per year).
High Growth Earnings: RADL3's earnings are forecast to grow, but not significantly.
Revenue vs Market: RADL3's revenue (12.3% per year) is forecast to grow faster than the BR market (6.7% per year).
High Growth Revenue: RADL3's revenue (12.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: RADL3's Return on Equity is forecast to be high in 3 years time (22.6%)
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/05/25 10:06 |
End of Day Share Price | 2025/05/23 00:00 |
Earnings | 2025/03/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Raia Drogasil S.A. is covered by 30 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Georgia Jorge | BB Banco de Investimento S.A. |
Robert Ford Aguilar | BofA Global Research |
Marcio Osako | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |